Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s-Reference-Cited by-同舟云学术

Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s

Published:2011-06-20 Issue:2 Volume:53 Page:185-196
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

McComsey G. A.,Kitch D.,Sax P. E.,Tebas P.,Tierney C.,Jahed N. C.,Myers L.,Melbourne K.,Ha B.,Daar E. S.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/53/2/185/804800/cir324.pdf

Reference23 articles.

1. Evidence of Nucleoside Analogue Reverse Transcriptase Inhibitor–Associated Genetic and Structural Defects of Mitochondria in Adipose Tissue of HIV-Infected Patients

2. Adverse effects of reverse transcriptase inhibitors

3. Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically

4. Body Fat and Other Metabolic Effects of Atazanavir and Efavirenz, Each Administered in Combination with Zidovudine plus Lamivudine, in Antiretroviral- Naive HIV-Infected Patients

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of menopause with cardiometabolic disease risk factors in women living with and without HIV in sub-Saharan Africa: Results from the AWI-Gen 1 study;Maturitas;2024-09

2. Coprevalence and associations of diabetes mellitus and hypertension among people living with HIV/AIDS in Cameroon;AIDS Research and Therapy;2024-06-01

3. Control of Body Weight;Textbook of Diabetes;2024-01-12

4. Comparing implications of cardiovascular risk of abacavir and integrase inhibitors: why scientific community is confused and timid?;AIDS;2023-05-01

5. Adipocyte differentiation of 3T3-L1 cells under tenofovir alafenamide, tenofovir disoproxil fumarate, and integrase strand transfer inhibitors selective challenge: an in-vitro model;AIDS;2022-12-13